Baird Honored to Attend ACS 2024

San Francisco, October 18-22, 2024 – Baird Medical was proud to be invited to showcase its cutting-edge microwave ablation (MWA) technology at the renowned American College of Surgeons (ACS) Clinical Congress, held at the Moscone Center in San Francisco.

As one of the largest surgical conferences globally, the ACS Clinical Congress brings together thousands of surgeons from diverse specialties to discuss the latest innovations and advancements in surgery. Baird Medical, stationed at Booth 1061, had the privilege of presenting its MWA solutions, used for the treatment of thyroid nodules, breast conditions, liver cancer, and uterine fibroids. This marked Baird's first appearance at the ACS event, and its participation was met with enthusiastic interest from surgeons worldwide.

Throughout the congress, Baird’s exhibit attracted significant attention from both new and experienced MWA users. Doctors from across North America, South America, the Middle East, and Asia participated in live demonstrations, experiencing first-hand the precision and efficiency of MWA in treating benign tumors. Surgeons from prestigious institutions, including Columbia University and the University of California, San Francisco, also engaged in thoughtful discussions about the future of ablative therapies.

In addition to the exhibit, Baird attended several key panels, including “Emerging Ablative Therapies for Breast Cancer” and “Thyroid Ablative Techniques: Nuances in Selection and Management.” The company also reconnected with esteemed collaborators such as Dr. Jennifer Kuo from Columbia University and Dr. Quan-Yang Duh from UCSF, reaffirming Baird’s commitment to advancing minimally invasive solutions for patients worldwide.

As the ACS congress concluded, Baird Medical reflected on the valuable connections made and the insights gained from surgeons and experts across the globe. The company remains dedicated to continued exploration and innovation, striving to provide the surgical community with precise and effective treatment options for the benefit of patients everywhere.

Disclaimer:
This communication contains forward-looking statements, including statements regarding Baird Medical’s participation in the ACS Clinical Congress and the potential benefits of its microwave ablation technology. These statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. Baird Medical does not assume any obligation to update these forward-looking statements. This post is intended for informational purposes only and should not be construed as an endorsement of specific medical devices or treatments. Always consult with a qualified healthcare professional before making medical decisions.